Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
US11046774B2 · kind B2 · utility
3Cited by
73References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2019 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Feb 25, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the antigen binding protein is administered in combination with a GLP-1 receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.